Ethyl 3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoate, 95%, 1g

ETHYL 2-(1-(TERT-BUTOXYCARBONYL)PIPERIDIN-3-YL)IMIDAZO[2,1-B][1,3,4]THIADIAZOLE-6-CARBOXYLATE, 90.0%, 1g

Matraces de fondo redondo ROTILABO® con borde rebordeado, cuello ancho, 250 ml, 10 Unidad(es)

(R)-tert-Butyl (2-oxopyrrolidin-3-yl)carbamate, 95.0%, 1g

1-Bromo-5-fluoro-2-methyl-4-nitrobenzene, 97.0%, 10g

5-Cyclopropyl-3-ethoxypyridine, 97%, 1g

2-Chloro-5-methylbenzaldehyde, 98%, 5g

N-[(1R,2R)-2-[[[[(1S,2S)-2-(Dimethylamino)cyclohexyl]amino]thioxomethyl]amino]-1,2-diphenylethyl]-3,5-bis(trifluoromethyl)benzenesulfonamide, 97%, 100mg

1-(2-Chloropyridin-3-yl)ethanol, 95.0%, 1g

[3-(cyanomethyl)phenyl]boronic acid, 95.0%, 250mg

Methyl 2-amino-2-ethylbutanoate, 98%, 250mg

Matraces de fondo redondo ROTILABO® con junta esmerilada, 6000 ml, 60/46, 1 Pieza

1-(4-Bromo-3-methylphenyl)-1H-pyrazole-4-carbaldehyde, 98%, 500mg